Cardiff Oncology(CRDF) - 2023 Q4 - Earnings Call Presentation

F Runway with current cash extends into 3Q 2025 Bev Naïve d all adverse or all adverse events entered into the EDC as of January 3, 2024, from an organing trial and unboked dratabase. N. number of potients revents shown occurred i the event, (regardless of causalitiy) each politient it a only counted once and only for the highest grade of a given event. TEAEs: Treatment Emergent Adverse Events; Gounm 33 Annual eligible US patients* In CRDF-004, each arm will have an equal number of FOLFIRI/bev and FOLFOX/be ...